Telmisartan, a dual ARB/partial PPAR-γ agonist, protects myocardium from ischaemic reperfusion injury in experimental diabetes

Diabetes, Obesity and Metabolism

Volumn 13, Issue 6, 2011, Pages 533-541

  Goyal, S N ^a   Bharti, S ^a   Bhatia, J ^a   Nag, T C ^a   Ray, R ^a   Arya, D S ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Antidiabetic drug; Antihypertensive therapy; Apoptosis; Cardiovascular disease; Diabetes; Diabetes complications; Diabetes mellitus; Drug mechanism; GW9662; Ischaemia reperfusion injury; Oxidative stress PPAR

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; CREATINE KINASE MB; LACTATE DEHYDROGENASE; MALONALDEHYDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN BAX; PROTEIN BCL 2; TELMISARTAN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; HEART CONTRACTION; HEART FUNCTION; HEART HEMODYNAMICS; HEART INFARCTION; HEART INFARCTION SIZE; HEART VENTRICLE PRESSURE; HISTOPATHOLOGY; MEAN ARTERIAL PRESSURE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; WESTERN BLOTTING;

EID: 79954994070     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2011.01377.x     Document Type: Article

References (38)

1. Gu K, Cowie CC, Harris MI. Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care 1998; 21: 1138-1145.
2. Zhang Y, Wei L, Sun D et al. Tanshinone IIA pretreatment protects myocardium against ischaemia/reperfusion injury through the phosphatidylinositol 3-kinase/Akt- dependent pathway in diabetic rats. Diabetes Obes Metab 2010; 12: 316-322.
3. Chinetti G, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm Res 2000; 49: 497-505.
4. Abdelrahman M, Sivarajah A, Thiemermann C. Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury, inflammation and shock. Cardiovasc Res 2005; 65: 772-781.
5. Thiemermann C, Wayman NS. Menarini Academy Cardiovascular Research Awards in Basic Science 2001: ligands of the orphan receptor peroxisome-proliferator activator-gamma reduce myocardial infarct size. Med Sci Monit 2001; 7: 787-789.
6. Sivarajah A, McDonald MC, Thiemermann C. The cardioprotective effects of preconditioning with endotoxin, but not ischemia, are abolished by a peroxisome proliferator-activated receptor-gamma antagonist. J Pharmacol Exp Ther 2005; 313: 896-901.
7. Collin M, Patel NS, Dugo L, Thiemermann C. Role of peroxisome proliferator-activated receptor-gamma in the protection afforded by 15-deoxydelta12, 14 prostaglandin J2 against the multiple organ failure caused by endotoxin. Crit Care Med 2004; 32: 826-831.
8. Yamagishi S, Takeuchi M. Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-gamma-inducing property. Med Hypotheses 2005; 64: 476-478.
9. Goebel M, Clemenz M, Unger T. Effective treatment of hypertension by AT(1) receptor antagonism: the past and future of telmisartan. Expert Rev Cardiovasc Ther 2006; 4: 615-629.
10. Mohanty IR, Arya DS, Gupta SK. Withania somnifera provides cardioprotection and attenuates ischemia-reperfusion induced apoptosis. Clin Nutr 2008; 27: 635-642.
11. Okhawa H, Oohishi N, Yagi N. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-358.
12. Moron MS, Depierre JW, Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 1979; 582: 67-78.
13. Cabaud P, Wroblewski F. Colorimetric measurement of lactic dehydrogenase activity of body fluid. Am J Clin Pathol 1958; 30: 234-236.
14. Aebi H. Catalase. In: Bergmeyer HU ed. Methods of Enzymatic Analysis. Maryland Heights, MO, USA: Academic Press Inc, 1974; 673-685.
15. Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974; 47: 469-474.
16. Bradford MM. A rapid and sensitive method for quantization of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
17. Singh AD, Amit S, Kumar OS et al. Cardioprotective effects of bosentan, a mixed endothelin type A and B receptor antagonist, during myocardial ischaemia and reperfusion in rats. Basic Clin Pharmacol Toxicol 2006; 98: 604-610.
18. Loh HK, Sahoo KC, Kishore K et al. Effects of thalidomide on isoprenaline-induced acute myocardial injury: a haemodynamic, histopathological and ultrastructural study. Basic Clin Pharmacol Toxicol 2007; 100: 233-239.
19. Mohanty I, Arya DS, Gupta SK. Effect of Curcuma longa and Ocimum sanctum on myocardial apoptosis in experimentally induced myocardial ischemic-reperfusion injury. BMC Complement Altern Med 2006; 6: 3-14.
20. Sukumaran V, Watanabe K, Veeraveedu PT et al. Telmisartan, an angiotensin receptor blocker ameliorates cardiac remodeling in rats with dilated cardiomyopathy. Hypertens Res 2010; 33: 695-702.
21. Wu L, Wang R, De Champlain J, Wilson TW. Beneficial and deleterious effects of rosiglitazone on hypertension development in spontaneously hypertensive rats. Am J Hypertens 2004; 17: 749-756.
22. Bolten CW, Payne MA, McDonald WG et al. Thiazolidinediones inhibit the progression of established hypertension in the Dahl salt-sensitive rat. Diab Vasc Dis Res 2007; 4: 117-123.
23. de Oliveira Silva-Junior G, da Silva Torres T, de Souza Mendonca L, Alberto Mandarim-de-Lacerda C. Rosiglitazone (peroxisome proliferator-activated receptor-gamma) counters hypertension and adverse cardiac and vascular remodeling in 2K1C hypertensive rats. Exp Toxicol Pathol 2011; 63: 1-7.
24. Wayman NS, Hattori Y, McDonald MC et al. Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size. FASEB J 2002; 16: 1027-1040.
25. Younis F, Stern N, Limor R et al. Telmisartan ameliorates hyperglycemia and metabolic profile in nonobese Cohen-Rosenthal diabetic hypertensive rats via peroxisome proliferator activator receptor-gamma activation. Metabolism 2010; 59: 1200-1209.
26. Nishimatsu H, Suzuki E, Takeda R et al. Blockade of endogenous proinflammatory cytokines ameliorates endothelial dysfunction in obese Zucker rats. Hypertens Res 2008; 31: 737-743.
27. Dhalla NS, Elmoselhi AB, Hata T, Makino N. Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc Res 2000; 47: 446-456.
28. Kumtepe Y, Odabasoglu F, Karaca M et al. Protective effects of telmisartan on ischemia/reperfusion injury of rat ovary: biochemical and histopathologic evaluation. Fertil Steril 2010; 93: 1299-1307.
29. Ye G, Metreveli NS, Donthi RV et al. Catalase protects cardiomyocyte function in models of type 1 and type 2 diabetes. Diabetes 2004; 53: 1336-1343.
30. Charan Sahoo K, Arora S, Goyal S et al. Cardioprotective effects of benazepril, an angiotensin-converting enzyme inhibitor, in an ischaemia-reperfusion model of myocardial infarction in rats. J Renin Angiotensin Aldosterone Syst 2009; 10: 201-209.
31. Huang E, Kuo W, Chen Y et al. Homocysteine and other biochemical parameters in type 2 diabetes mellitus with different diabetic duration or diabetic retinopathy. Clin Chim Acta 2006; 366: 293-298.
32. Hagar HH. Folic acid and vitamin B12 supplementation attenuates isoprenaline-induced myocardial infarction in experimental hyperhomocysteinemic rats. Pharmacol Res 2002; 46: 213-219.
33. Goyal BR, Mesariya P, Goyal RK, Mehta AA. Effect of telmisartan on cardiovascular complications associated with streptozotocin diabetic rats. Mol Cell Biochem 2008; 314: 123-131.
34. Crow MT, Mani K, Nam YJ, Kitsis RN. The mitochondrial death pathway and cardiac myocyte apoptosis. Circ Res 2004; 95: 957-970.
35. Liu HR, Tao L, Gao E et al. Anti-apoptotic effects of rosiglitazone in hypercholesterolemic rabbits subjected to myocardial ischemia and reperfusion. Cardiovasc Res 2004; 62: 135-144.
36. Cao Z, Ye P, Long C, Chen K, Li X, Wang H. Effect of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on ischemia-reperfusion injury in rats. Pharmacology 2007; 79: 184-92.
37. Ikejima H, Imanishi T, Tsujioka H et al. Effects of telmisartan, a unique angiotensin receptor blocker with selective peroxisome proliferator-activated receptor-gamma-modulating activity, on nitric oxide bioavailability and atherosclerotic change. J Hypertens 2008; 26: 964-972.
38. Kobayashi N, Ohno T, Yoshida K et al. Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive rats. Am J Hypertens 2008; 21: 576-581.